Drug firms test medicines to halt Alzheimer's before symptoms appear

By The Boston Globe
| August 31, 2023

A study hopes to determine whether Leqembi will produce more dramatic benefits to people who have yet to show signs of cognitive decline and memory loss.

Full story

#1

Physicians are in short supply. They are costly. Is the APP the answer to the CMO's workforce and budget challenges? ...

Amid the hype and promise, a growing tension is becoming clear: the reality of what AI can deliver versus what it can't. ...